Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey

AIDS

Volumn 26, Issue 8, 2012, Pages 971-975

  Lambert Niclot, Sidonie ^a,b,c   Tubiana, Roland ^b,c,d   Beaudoux, Céline ^b   Lefebvre, Gilles ^e   Caby, Fabienne ^b,c,d   Bonmarchand, Manuela ^f   Naouri, Michèle ^e   Schubert, Benoit ^a   Dommergues, Marc ^e   Calvez, Vincent ^a,b,c   Flandre, Philippe ^a,b,c   Poirot, Catherine ^a,c   Marcelin, Anne Geneviève ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Service des Maladies Infectieuses et Tropicales   (France)

^e Service de Gynecologie Obstetrique   (France)

^f Service de Médecine Interne   (France)

Author keywords

HIV 1; HIV 1 proviral DNA; residual viremia; semen; shedding

Indexed keywords

ABACAVIR; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; SEMINAL PLASMA; VIREMIA; VIRUS DETECTION; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEMEN; VIRAL LOAD;

EID: 84861096473     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328352ae09     Document Type: Review

References (27)

1. Englert Y, Van Vooren JP, Liesnard C, Laruelle C, Delbaere A. Medically assisted reproduction and the desire for a child by HIV infected couples: has the time for a change in attitude come? Gynecol Obstet Fertil 2001; 29:339-348.
2. Leruez-Ville M, Dulioust E, Costabliola D, Salmon D, Tachet A, Finkielsztejn L, et al. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: An 18 month longitudinal study (ANRS EP012). AIDS 2002; 16:486-488.
3. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14:117-121.
4. Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 2004; 18:757-766.
5. Dulioust E, Leruez-Ville M, Guibert J, Fubini A, Jegou D, Launay O, et al. No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002-2009 survey. AIDS 2010; 24:1595-1598.
6. Marcelin AG, Tubiana R, Lambert-Niclot S, Lefebvre G, Dominguez S, Bonmarchand M, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008; 22:1677-1679.
7. Pasquier C, Saune K, Raymond S, Moinard N, Daudin M, Bujan L, et al. Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy. J Clin Microbiol 2009; 47:2883-2887.
8. Sheth PM, Kovacs C, Kemal KS, Jones RB, Raboud JM, Pilon R, et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009; 23:2050-2054.
9. Barreiro P, Castilla JA, Labarga P, Soriano V. Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod 2007; 22:2353-2358.
10. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV-infected people not suffering from any other STD and following an effective antiretroviral treatment does not transmit HIV through sexual intercourse. Bulletin des Médecins Suisses 2008; 89:165-169.
11. Chun TW, Murray D, Justement JS, Hallahan CW, Moir S, Kovacs C, et al. Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. J Infect Dis 2011; 204:135-138.
12. Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: Results from the European CREAThE network. AIDS 2007; 21:1909-1914.
13. Leruez-Ville M, de Almeida M, Tachet A, Dulioust E, Guibert J, Mandelbrot L, et al. Assisted reproduction in HIV-1-serodifferent couples: The need for viral validation of processed semen. AIDS 2002; 16:2267-2273.
14. Pasquier C, Anderson D, Andreutti-Zaugg C, Baume-Berkenbosch R, Damond F, Devaux A, et al. Multicenter quality control of the detection of HIV-1 genome in semen before medically assisted procreation. J Med Virol 2006; 78:877-882.
15. Avettand-Fenoel V, Chaix ML, Blanche S, Burgard M, Floch C, Toure K, et al. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). J Med Virol 2009; 81:217-223.
16. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2003; 41:4531-4536.
17. Ghosn J, Chaix ML, Peytavin G, Bresson JL, Galimand J, Girard PM, et al. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. J Antimicrob Chemother 2008; 61:1344-1347.
18. Lambert-Niclot S, Peytavin G, Duvivier C, Poirot C, Algarte-Genin M, Pakianather S, et al. Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavirritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy. Antimicrob Agents Chemother; 2010; 54:4910-4913.
19. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
20. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010; 375:2092-2098.
21. Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 2011; 25:473-477.
22. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 2009; 373:48-57.
23. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
24. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: A systematic review and meta-analysis. Lancet Infect Dis 2008; 8:553-563.
25. Vandermaelen A, Englert Y. Human immunodeficiency virus serodiscordant couples on highly active antiretroviral therapies with undetectable viral load: Conception by unprotected sexual intercourse or by assisted reproduction techniques? Hum Reprod 2010; 25:374-379.
26. Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral quasi species between blood and semen. J Infect Dis 2000; 182:79-87.
27. Ghosn J, Chaix ML. Combined antiretroviral therapy is effective on blood plasma HIV-1-RNA: what about semen HIV-1-RNA levels? AIDS; 2010 24:309-311.